Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among ...

Published in AIDS Research and Therapy

BackgroundThe aim of this study was to investigate the effectiveness and tolerability of the combination elvitegravir/cobicistat/tenofovir/emtricitabine plus darunavir (EVG/COB/TFV/FTC + DRV) in treatment-experienced patients from the cohort of the Spanish HIV/AIDS Research Network (CoRIS).MethodsTreatment-experienced patients starting treatment wi...